Back to search

Netherlands· NL-4143879af8b1

Cholecalciferol 25.000 IE Focus Care, zachte capsules

A colecalciferol product containing cholecalciferol + cholecalciferol, registered in Netherlands by Focus Care Pharmaceuticals B.V.. The same ATC class is registered in 16 of our 19 countries.

ATC A11CC05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedCholecalciferol 25.000 IE Focus Care,…ATCA11CC05REGISTER NO.NL-4143879af8b1PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Colecalciferol is registered in 16 of 19 countries.

Countries holding a registration under ATC A11CC05 (colecalciferol), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose

Colecalciferol · ATC A11CC05

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CHOLECALCIFEROL + CHOLECALCIFEROL
Manufacturer
Focus Care Pharmaceuticals B.V.
Country
Netherlands (NL)
ATC code
A11CC05
ATC class
Colecalciferol
Defined daily dose
20 mcg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    124981

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

68 interactions on record for colecalciferol.

Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Colecalciferol · interactions on record

68 records

  • 10 severe
  • 56 moderate
  • 2 minor

Most severe, free to view

  • ErgocalciferolA11CC01severe
  • DihydrotachysterolA11CC02severe
  • CalcitriolA11CC04severe
  • CalcifediolA11CC06severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Colecalciferol in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All colecalciferol products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Colecalciferol Fresenius, Colecalciferol Invos
  • Belgium · Colecaps, D-Cure
  • Bulgaria · D-Vital, Dekristol
  • Cyprus · Cholecalciferol Aviral, Deltius
  • Czechia · Deprovit, Ditralia
  • Germany · Cholecalciferol 089pharm, Cholecalciferol Mibe
  • Denmark · Benferol, Cholecalciferol Strides
  • Estonia · Adervia, Boncel
  • Spain · Aldexina, Benferol
  • Finland · Divifarm, Divisun
  • France · Adrigyl, Cholecalciferol
  • United Kingdom (Northern Ireland) · Aviticol, Cholecalciferol Zentiva
  • Greece · Adapton D, Calcifenov
  • Croatia · D-Vital, Dekristol
  • Hungary · Colecalciferol Farmaprojects, D-Vitamin Eurovit
  • Ireland · Altavitad3, Cholecalciferol Strides Pharma Cyprus
  • Italy · Annexxo, Annister
  • Lithuania · Adervia, Aquadetrim
  • Luxembourg · Cholécalciférol Fultivit-D3, D-Cure
  • Latvia · Adervia, Boncel
  • Malta · Altavitad3, Cholecalciferol Pharmacare
  • Norway · Benferol, Cholecalciferol Afortas
  • Poland · Apod3 Med, Boncel
  • Portugal · Aldexina, Colecalciferol
  • Romania · Bonfal, Vigantol Oil
  • Sweden · Benferol, Cholecalciferol Afortas
  • Slovenia · Docile, Holekalciferol Krka
  • Slovakia · Fultium, Olvit D3

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b40f05de-9f06-4f32-bf88-ea5d36a1c82b
GET /v1/drugs/b40f05de-9f06-4f32-bf88-ea5d36a1c82b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, zacht",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h124981_smpc.pdf",
  "strength": null,
  "atc_label": "Colecalciferol",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg124981",
  "excipients": [
    "GELATINE (E 441)",
    "GLYCEROL (E 422)",
    "PONCEAU 4R (E 124)",
    "SORBITOL VLOEIBAAR, GEDEELTELIJK GEDEHYDRATEERD",
    "TOCOFEROL, DL-ALFA ACETAAT",
    "TRIGLYCERIDEN MIDDELLANGE KETEN",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "CHOLECALCIFEROL",
    "CHOLECALCIFEROL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h124981.pdf",
  "authorised_at": "2020/08/14",
  "procedure_number": "NL/H/4893/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "124981",
  "additional_monitoring": "N"
}

See everything about colecalciferol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.